நாடின் ரோஜர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

5 Min Read PARIS (Reuters) - A 60-year-old recovering from breast cancer, Paris resident Nadine Roger is at high-risk from COVID-19 and wants to get vaccinated as soon as possible. Yet when she was offered the vaccine manufactured by AstraZeneca she turned it down. “The AstraZeneca (shot) frightens me,” she said. Roger, a medical technician, said she would wait instead for the shot made by U.S. firm Johnson & Johnson, which has not yet been approved by European regulators. According to the most recent data made available by the French health ministry, for the end of February, France was using 24% of its AstraZeneca doses, compared with 82% for vaccines made by Pfizer/BioNTech and 37% for the Moderna shot.

France generalUnited kingdomLea guedjOlivier natafRichard loughChristian loweNadine rogerAlex richardsonJacques battistoniCaroline pailliezThomson reuters trust principlesPresident emmanuel macronAstrazeneca franceThomson reuters trustCorona virusDrug amp device development